BIO-CHEM(SH:603360)2023-10-26 16:00Main Financial Data Key Accounting Data and Financial Indicators In Q3 2023 and YTD, the company's operating revenue and net profit both declined year-on-year, while total assets and shareholder equity increased Core Financial Indicators for Q3 and YTD 2023 | Metric | Current Period (Q3) | YoY Change (%) | YTD (Year-to-Date) | YoY Change (%) | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 277,849,559.89 RMB | -19.13% | 850,885,355.13 RMB | -15.25% | | Net Profit Attributable to Shareholders of Listed Company | 93,078,538.81 RMB | -14.15% | 282,936,730.02 RMB | -15.80% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) | 92,650,301.27 RMB | -15.67% | 281,426,506.03 RMB | -16.28% | | Net Cash Flow from Operating Activities | N/A | N/A | 321,478,353.04 RMB | -12.85% | | Basic Earnings Per Share (RMB/share) | 0.26 RMB | -16.13% | 0.80 RMB | -15.79% | Key Balance Sheet Indicators at Period End | Metric | End of Current Period | End of Previous Year | Change (%) | | :--- | :--- | :--- | :--- | | Total Assets | 1,859,049,848.13 RMB | 1,754,392,289.92 RMB | 5.97% | | Total Equity Attributable to Shareholders of Listed Company | 1,586,524,072.55 RMB | 1,461,271,081.01 RMB | 8.57% | Non-recurring Gains and Losses and Amounts Non-recurring gains and losses primarily from government grants totaled 1.51 million RMB YTD after tax impact Details of Non-recurring Gains and Losses (YTD) | Item | Amount (RMB) | | :--- | :--- | | Government Grants Included in Current Period's Profit/Loss | 1,755,943.56 | | Other Non-operating Income and Expenses | 20,790.55 | | Less: Income Tax Impact | -266,510.12 | | Total | 1,510,223.99 | Shareholder Information Shareholding Status of Shareholders As of period end, the company had 13,680 common shareholders; top two hold 58.39%, with some shares pledged or frozen - As of the end of the reporting period, the company had 13,680 common shareholders10 Shareholding and Share Status of Top Two Shareholders | Shareholder Name | Shareholding Percentage (%) | Share Status | Quantity (shares) | | :--- | :--- | :--- | :--- | | Dalian Tongyun Investment Co., Ltd. | 29.96% | Pledged | 51,550,000 shares | | Dalian Sanxin Investment Co., Ltd. | 28.43% | Frozen | 102,442,508 shares | Other Reminders - The company has no other significant operating information requiring special attention from investors during this reporting period13 Quarterly Financial Statements Consolidated Balance Sheet As of Sept 30, 2023, total assets grew 5.97% to 1.859 billion RMB, and total liabilities decreased 7.03%, optimizing the financial structure Key Balance Sheet Item Changes | Item | Sept 30, 2023 (RMB) | Dec 31, 2022 (RMB) | Change (%) | | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 501,293,096.26 | 417,962,525.12 | 19.94% | | Prepayments | 80,502,691.76 | 22,169,644.46 | 263.12% | | Total Assets | 1,859,049,848.13 | 1,754,392,289.92 | 5.97% | | Short-term Borrowings | 130,010,138.89 | 129,112,861.11 | 0.69% | | Total Liabilities | 272,525,775.58 | 293,121,208.91 | -7.03% | | Total Equity Attributable to Parent Company Shareholders | 1,586,524,072.55 | 1,461,271,081.01 | 8.57% | Consolidated Income Statement YTD 2023, total operating revenue decreased 15.25% to 851 million RMB, and net profit attributable to parent shareholders declined 15.80% Key Income Statement Items (YTD 2023) | Item | Jan-Sep 2023 (RMB) | Jan-Sep 2022 (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | 850,885,355.13 | 1,004,001,614.53 | -15.25% | | Operating Cost | 396,439,803.63 | 467,899,394.34 | -15.27% | | R&D Expenses | 29,415,397.33 | 41,506,216.37 | -29.13% | | Financial Expenses | -8,841,918.55 | -23,031,448.80 | N/A | | Operating Profit | 327,345,889.05 | 401,450,955.00 | -18.46% | | Net Profit Attributable to Parent Company Shareholders | 282,936,730.02 | 336,012,652.95 | -15.80% | | Basic Earnings Per Share (RMB/share) | 0.80 | 0.95 | -15.79% | Consolidated Cash Flow Statement YTD 2023, net cash flow from operating activities decreased 12.85% to 321 million RMB, with cash and cash equivalents significantly increasing at period end Key Cash Flow Statement Items (YTD 2023) | Item | Jan-Sep 2023 (RMB) | Jan-Sep 2022 (RMB) | YoY Change (%) | | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 321,478,353.04 | 368,864,632.30 | -12.85% | | Net Cash Flow from Investing Activities | -59,966,113.76 | -122,000,119.86 | 50.85% | | Net Cash Flow from Financing Activities | -159,101,559.84 | -196,238,561.16 | 18.92% | | Net Increase in Cash and Cash Equivalents | 103,822,083.95 | 53,899,620.22 | 92.62% | | Cash and Cash Equivalents at Period End | 499,201,018.38 | 266,172,008.43 | 87.55% |